Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO scheduling for chemotherapy-induced thrombocytopenia in non-Hodgkin lymphoma
ChiCTR-OPB-15007591Phase 4Recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Oct 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of recombinant human thrombopoietin in Thrombocytopenia (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Incidence of thrombocytopenia. Started Oct 2014; status: recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on ChiCTR-OPB-15007591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPB-15007591.